Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Issue: Unauthorized product
Remove filter for
Recall class: Type II
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 14 of 14 items.
Product imported and marketed without market authorization (DIN) in Canada.
RecallHealth product recall | 2023-11-03
Affected lots contain an undeclared ingredient (bimatoprost). Product sold without market authorization (DIN) in Canada.
RecallHealth product recall | 2023-10-12
Affected lots contain an undeclared ingredient (bimatoprost). Product sold without market authorization (DIN) in Canada.
RecallHealth product recall | 2023-08-21
Product sold without market authorization (DIN) in Canada. Product contains undeclared ingredient, bimatoprost, that is listed on the prescription drug list
RecallHealth product recall | 2023-08-18
Product sold without market authorization DIN in Canada.
RecallHealth product recall | 2023-08-03
Product sold without market authorization (DIN) in Canada.
RecallHealth product recall | 2023-05-30
Product sold without market authorization (DIN) in Canada. Affected lot contains undeclared Dehydrolatanoprost, a prostaglandin analogue. Prostaglandin analogues are listed in the prescription drug list
RecallHealth product recall | 2023-04-27
Unauthorized health products for use in the pediatric subpopulation.
RecallHealth product recall | 2023-04-27
Product sold without market authorization (DIN) in Canada.
RecallHealth product recall | 2023-04-20
Product sold without market authorization (DIN) in Canada.
RecallHealth product recall | 2023-04-04
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list. Test results for Lot 20220331 found the product to contain bimatoprost.…
RecallHealth product recall | 2022-09-26
The affected lots may contain an undeclared ingredient, bimatoprost, listed on the prescription drug list.
RecallHealth product recall | 2022-07-11
All lots contain undeclared Isopropyl Cloprostenate that is listed on the prescription drug list.
RecallHealth product recall | 2022-04-19
Product sold without market authorization (NPN) in Canada.
RecallHealth product recall | 2021-12-10